Texas · 89th Legislature (2025) · Bill
HB 350: Relating to the use of glucagon medication on certain public and private school campuses.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 350 is a bill introduced in the Texas House on November 12, 2024. According to its official title, it concerns: Relating to the use of glucagon medication on certain public and private school campuses. Primary sponsor: James Talarico (Democratic). Most recent recorded action (February 28, 2025): Referred to Public Education.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| James Talarico | Primary sponsor | Democratic | House | 50 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to Public Education
- Read first time
- Filed